Compass Pathways PLC expected to post a loss of 45 cents a share - Earnings Preview

What happened

Compass Pathways PLC is expected to report no change in quarterly revenue for the period ending September 30, 2026, according to LSEG's mean analyst estimate. Analysts expect a loss of 45 cents per share when results are reported on November 3.

Confirmed

Global impact / market context

A loss of 45 cents per share means analysts expect the company to spend more than it earns, which is common for drug developers funding research. Flat revenue suggests no new product sales are expected, so cash reserves and spending discipline will likely drive investor views.

Analyst inference

Most covering analysts rate the shares a buy, and the median 12-month price target of $20.00 is about 64.1% above the last close of $12.19. That gap suggests analysts see possible upside despite expected losses.

Analyst inference

What to watch

1. Watch whether reported revenue matches the prior-year quarter, since the estimate calls for no change for the period ending September 30, 2026. Confirmed
2. Watch whether the company explains planned research spending, because higher spending would increase cash use and could widen future losses beyond the current 45-cent estimate. Proposed
3. Watch whether management gives updates on study progress, since positive trial news could support the $20.00 median price target while delays could pressure shares. Analyst inference

Evidence

• Original source link unavailable